The PTMG Spring Conference in Munich brought together trademark and pharmaceutical industry professionals to discuss key developments shaping the sector.
Our partner Urko Ochoa, Head of our Life Sciences practice, participated in this year’s conference, engaging in discussions that are central to our work and our clients’ needs.
The program covered topics such as WIPO’s digital harmonization efforts, pharmaceutical trademark litigation, and recent international case law, alongside broader discussions on post-sale confusion, damages for trademark infringement, and the growing relevance of copyright in pharma. It also addressed market-driven issues, including reference pricing policies in Europe and the U.S., emerging IP trends in African markets, and the critical link between trademarks and patient safety.
For us, being at PTMG is about staying closely connected to the realities our clients face and to ensuring we can anticipate and navigate their impact in Dominican Republic and across the Caribbean.
